By: Ada Seldin, Staff Editor - On November 22, 2013, simeprevir (Olysio®), a new agent to treat chronic hepatitis C,…
By: Ramya Mathew, PharmD Candidate c/o 2015 - Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been…
By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…
By: Andy Zhang, PharmD Candidate c/o 2015 - On March 28, 2013, the U.S. Food and Drug Administration announced the…
By: Maria Sorbera, PharmD Candidate c/o 2013, AMSCOP, LIU - Hepatitis C is the leading cause of chronic liver disease…